SELB - Selecta BiosciencesAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $3.19 | Open | $3.18 |
| Volume | 951.4K | Market Cap | 347.86M |
| Yield | Last Dividend |
| Selecta Biosciences Reports Third Quarte... | 11/05/20 |
| Phase 3 DISSOLVE clinical program with Sobi ongoing to evaluate SEL-212; topline data expected in the second half of 2022IND filing for gene therapy??... | |
| Selecta Biosciences News: SELB Stock Sho... | 10/26/20 |
| Selecta Biosciences (SELB) news for Monday includes insider buying from a Board of Directors member sending SELB stock higher. | |
| Last Week's Notable Insider Buys: Del Ta... | 10/25/20 |
| Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Some insiders were buying shares in the wake of ear... | |
| Timothy A. Springer Buys 1,770,204 Share... | 10/24/20 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) Director Timothy A. Springer purchased 1,770,204 shares of the firm???s stock in a transaction on Thursday, Oc... | |
| Insider Buying: Selecta Biosciences, Inc... | 10/23/20 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) Director Timothy A. Springer bought 1,770,204 shares of the stock in a transaction on Thursday, October 22nd. ... | |
| Selecta Biosciences, Inc. (NASDAQ:SELB) ... | 10/23/20 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) Director Timothy A. Springer purchased 218,196 shares of the firm???s stock in a transaction on Friday, Octobe... | |
| Selecta Biosciences (NASDAQ:SELB) Tradin... | 10/23/20 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) traded up 19.3% during trading on Wednesday following insider buying activity. The stock traded as high as $2.... | |
| Selecta Biosciences (NASDAQ:SELB) Tradin... | 10/21/20 |
| Shares of Selecta Biosciences, Inc. (NASDAQ:SELB) shot up 19.3% on Wednesday after an insider bought additional shares in the company. The company tra... | |
| Selecta Biosciences (NASDAQ:SELB) Shares... | 10/21/20 |
| Shares of Selecta Biosciences, Inc. (NASDAQ:SELB) rose 19.3% during trading on Wednesday after an insider bought additional shares in the company. The... | |
| Why Selecta Biosciences Stock Is Trading... | 10/21/20 |
| Selecta Biosciences (NASDAQ: SELB ) shares are trading higher on Wednesday potentially after its director Timothy Springer reported the purchase of 1,... | |
| Timothy A. Springer Buys 1,887,696 Share... | 10/20/20 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) Director Timothy A. Springer acquired 1,887,696 shares of the firm???s stock in a transaction that occurred on... | |
| Timothy A. Springer Buys 218,196 Shares ... | 10/20/20 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) Director Timothy A. Springer bought 218,196 shares of the company???s stock in a transaction that occurred on ... | |
| Insider Weekends: Liquidity Services Ris... | 10/12/20 |
| Insider buying decreased last week. Notable Insider Buys: Element Solutions Inc, Selecta Biosciences, Inc., Liquidity Services, Inc., Medtronic plc, A... | |
| Last Week's Notable Insider Buys: Elemen... | 10/11/20 |
| Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insiders seemed to be focused on biotech companies ... | |
| Selecta Bio inks research pact with IGAN... | 10/08/20 |
| Selecta Biosciences (NASDAQ:SELB) and privately-held IGAN Biosciences, have entered into a research license and option agreement to study former's Imm... | |
| The Week Ahead In Biotech: Avenue's FDA ... | 10/04/20 |
| Biotech stocks made a steady recovery over the week ended Oct. 2, although Friday's weakness trimmed some of the gains of the week. Companies working ... | |
| Why Horizon Therapeutics, Selecta Biosci... | 10/01/20 |
| Shares of Horizon Therapeutics PLC (NASDAQ: HZNP), which focuses on rare and rheumatic diseases, surged higher Thursday despite an absence of announce... | |
| 5 Stocks To Watch For October 1, 2020 | 10/01/20 |
| Some of the stocks that may grab investor focus today are: Wall Street expects PepsiCo, Inc. (NASDAQ: PEP ) to report quarterly earnings at $1.49 per ... | |
| The Daily Biotech Pulse: Tiziana Snags A... | 06/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) ADC... | |
| Sarepta Therapeutics and Selecta Bioscie... | 06/18/20 |
| Application of ImmTOR plus Sarepta???s investigational gene therapies will be evaluated for Duchenne Muscular Dystrophy and Limb-Girdle Muscular Dystr... | |
| Selecta Biosciences Reports First Quarte... | 05/07/20 |
| - Topline data announcement from the ongoing head-to-head COMPARE trial of SEL-212 remains on schedule for Q3 2020 - - Phase 3 clinical program of SEL... | |
| Earnings Scheduled For March 12, 2020 | 03/12/20 |
| Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of ... | |
| Selecta Biosciences to Host Conference C... | 03/05/20 |
| WATERTOWN, Mass., March 05, 2020 -- Selecta Biosciences, Inc. , a clinical-stage biotechnology company focused on unlocking the full potential of biol... | |
| The Daily Biotech Pulse: LogicBio Slappe... | 02/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) ... | |
| ObsEva and Selecta Bio up premarket on b... | 01/29/20 |
| ObsEva (NASDAQ:OBSV) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up 8% premarket. Selecta Biosciences (NASDAQ:... | |
| The Daily Biotech Pulse: Roche Reports P... | 01/23/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) ... | |
| Selecta Biosciences Sees Hammer Chart Pa... | 06/21/19 |
| Selecta Biosciences has been struggling lately, but the selling pressure may be coming to an end soon. | |
| Selecta Biosciences, Inc. (SELB) CEO Car... | 05/14/19 |
| Selecta Biosciences, Inc. (NASDAQ:SELB) Q1 2019 Results Conference Call May 9, 2019 08:30 AM ET Company Participants Elona Kogan - General Counsel & C... | |
| Peloton IPO: Expects To Start Phase 3 Tr... | 05/09/19 |
| No summary available. | |
| Selecta Biosciences beats by $0.04 | 05/09/19 |
| No summary available. | |
| Buy rating | 10/05/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $10.00 to $6.00 | |
| Hold rating | 10/01/20 |
| Mizuho downgrades from Buy to Neutral rating and lowers Price Target from $7.00 to $2.50 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| THE COMEBACK SEASON | JOHN KROLIKOWSKI | 85.00 % | Follow |
| BLOWBACK II | JOHN KROLIKOWSKI | 50.00 % | Follow |
| Biotech picks | mr jackson | 50.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
